Table 1:
Characteristics of patients with CAA
| Patient Characteristic | n = 50 |
|---|---|
| Probable CAA, n (%) | 43 (86.0) |
| Biopsy proved, n (%) | 12 (24.0) |
| Possible CAA, n (%) | 7 (14.0) |
| Neurologic outcomes | |
| Ischemic stroke, n (%) | 35 (70.0) |
| Hemorrhage, n (%) | 23 (46.0) |
| Both, n (%) | 19 (38.0) |
| VWE | 29 (58.0) |
| Clinical confounders | |
| Maximum percent stenosis, mean (SD) | 14.9 (20.8) |
| Age, mean (SD), y | 71.9 (7.7) |
| Female sex, n (%) | 27 (54.0) |
| Hypertension, n (%) | 43 (86.0) |
| Hyperlipidemia, n (%) | 32 (64.0) |
| Diabetes, n (%) | 14 (28.0) |
| Smoking, n (%) | 19 (38.0) |
| Antiplatelet, n (%) | 18 (36.0) |
| Anticoagulation, n (%) | 5 (10.0) |
| Antihypertension, n (%) | 37 (74.0) |
| Statin, n (%) | 27 (54.0) |
| Time between symptom onset and MR imaging in days, mean (SD) | 3.9 (2.6) |
| Inflammatory marker elevation, n (%), n = 30 available | 10 (33.3) |